NARSAD
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Robert C. Malenka, M.D., Ph.D. (Distinguished Investigator 2007) of Stanford University, aims to use an animal model to study the role of the brain’s striatum in mental illness. Evidence suggests the striatum plays a role in depression, schizophrenia and obsessive-compulsive disorder. Moreover, the striatum receives dense dopaminergic innervation, and dysfunction of the dopaminergic modulation of striatal circuits has been associated with both depression and schizophrenia. The striatum is divided into dorsal and ventral components, but appears homogeneous because >95 percent of its cells are medium spiny neurons (MSNs). But cortical and limbic afferents make excitatory synapses onto two distinct populations of MSNs that are part of two independent parallel circuits known as the direct (or striatonigral) and indirect (striatopallidal) pathways. These two MSN populations differ in their neurotransmitter receptor and neuropeptides expression. A limitation to understanding striatal circuitry has been the lack of knowledge about possible physiological differences between the different MSN populations, which have been assumed to have similar, if not identical, synaptic and electrophysiological properties. However, a newly engineered transgenic mouse allows scientists to now see cell-type specific expression of green fluorescent protein in distinct neuronal subpopulations, including MSNs of the direct and indirect pathways in both dorsal and ventral striatum. These mice provide a previously unavailable resource to characterize the cellular and synaptic properties of neurons in these subpopulations. Indeed, Dr. Malenka has found (Nature, in press) clear differences in the function and plasticity of synapses on dopamine Dl receptor-expressing, direct pathway MSNs versus D2 receptor-expressing indirect pathway MSNs. Furthermore, the modulation of synaptic plasticity by dopamine appears to be different in these distinct MSN populations. In this proposal, Dr. Malenska plans on studying the following hypothesis: that excitatory synapses on MSNs of the indirect and direct pathways exhibit different properties and that these differences are functionally important both for adaptive brain functions and during brain disorders, such as depression. Results may lead to a better understanding of the pathophysiology of mental illness and to new approaches for drug development.

Program Area: BASAL GANGLIA DISEASES

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award Application Deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Awards Earliest Start Date: September 15, 2008

2009 Independent Investigator Award Application Deadline: March 5, 2009

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009
NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us